Article
CACNA1C as a Prognostic Biomarker and Therapeutic Target in High-Grade Serous Ovari-an Cancer: Clinical Validation and Molecular Dynamics of Nifedipine Blockade
2026-04-22
Abstract excerpt
High-Grade Serous Ovarian Cancer (HGSOC) is the most lethal gynecological malignancy due to aggressive growth, widespread metastases, and high intra-tumoral heterogeneity. Poor prognosis is largely due to late diagnosis, hence there is an urgent need to identify novel biomarkers for screening, diagnosis, and monitoring. Here, we propose the voltage-dependent calcium channel hCaV1.2 encoded by CACNA1C as a potentia...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f63fc17d-3bed-57eb-a10c-abd1a01cb954
- DOI
- 10.64898/2026.04.19.719516
